Electrical impedance spectroscopy detects skin barrier dysfunction in childhood atopic dermatitis

Mari Sasaki1, Mathilda Sundberg2, Remo Frei3,4,5

  • 1University Children's Hospital Zürich, Zürich, Switzerland.

Allergy
|September 27, 2023
PubMed

Insights

Electrical impedance spectroscopy (EIS) can detect skin barrier dysfunction in children, differentiating atopic dermatitis (AD) affected skin from healthy skin. This method shows potential for predicting future AD development in children.

Area of Science:

  • Dermatology
  • Biomedical Engineering
  • Pediatrics

Background:

  • Skin barrier dysfunction is a known factor in atopic dermatitis (AD) development.
  • Current methods for assessing skin barrier function are limited.
  • Electrical impedance spectroscopy (EIS) is explored as a novel assessment tool.

Purpose of the Study:

  • To investigate the utility of EIS in detecting skin barrier dysfunction in children with AD.
  • To develop and validate a machine learning algorithm using EIS for AD diagnosis.
  • To assess the association of EIS measurements with clinical characteristics and age.

Main Methods:

  • EIS measurements were collected from infants and young children (4 months to 3 years) in the CARE cohort.
  • A machine learning algorithm (EIS/AD score) was developed using EIS data and AD status.
  • The diagnostic performance of the EIS/AD score was evaluated and compared to clinical data.

Main Results:

  • The EIS algorithm effectively distinguished between healthy skin and clinically unaffected skin of children with active AD (AUC 0.92).
  • EIS detected differences even in children without active AD, indicating subclinical changes.
  • No significant association was found between the EIS/AD score and AD severity or allergen sensitization; age did not affect performance.

Conclusions:

  • EIS is a viable method for detecting skin barrier dysfunction in children.
  • EIS can differentiate between healthy and AD-affected skin, with potential for predicting future AD development.
  • The EIS/AD score demonstrates diagnostic capability irrespective of age or disease severity.
Abstract